Accelerate bench-to-clinic translation with dedicated low-volume pilot synthesis, method establishment, and specialized preclinical validation.
Target validation, enzymatic bio-assays, and cell-based potency profiling tailored for regulated small-batch discovery runs.
Explore Service
Precision chromatographic mapping across harvests to calibrate yield stability prior to clinical formulation.
Explore Service
High-throughput screening platforms identifying targeted alkaloids, flavonoids, and active functional bio-polymers.
Explore Service
Pharmacokinetic profiling, toxicity assessments, and in-depth LD50 confirmation on compliant pilot-grade batches.
Explore Service
HPTLC, HPLC-MS, and GC methodology design, validation, and standard establishment adhering to global pharmacopeias.
Explore Service
Multi-center clinical trial support, GCP-compliant documentation, and patient registry data management for global NDAs.
Explore Service
Fractionation and isolated structural identification for high-purity natural molecular scaffolds and raw actives.
Explore Service
Comprehensive chemical mapping and lot-to-lot consistency protocols engineered for scalable tech transfer.
Explore ServiceThe shift toward customized botanicals, targeted therapeutic formulations, and fast iterative regulatory trials has redefined conventional high-volume batch contracting.
Global pharmaceutical procurement protocols frequently stall when moving straight from laboratory benches to metric-ton production. Small-batch manufacturing acts as the vital engineering buffer, generating representative pilot batches for preliminary toxicity assays, stability chambers, and early-phase human trials without excessive upfront capital outlay.
Positioned at the origin of comprehensive raw botanical biodiversity, China-based CDMO manufacturers like MedGence bridge endemic agricultural mastery with state-of-the-art cGMP extraction frameworks. The result is rapid turnaround, lower tooling costs, and immediate geographic access to thousands of certified herbal species.
Small-batch runs eliminate cross-contamination through closed-loop modular suites. Proprietary extraction parameters, custom enzyme ratios, and specialized spray drying parameters remain strictly preserved within secure non-disclosure boundaries throughout the product lifecycle.
A side-by-side engineering breakdown illustrating why specialized small-batch manufacturing delivers superior information gain and risk containment during formulation development.
| Critical Engineering Metric | MedGence Agile Small Batch Pilot Run | Conventional High-Volume Factory Run | Client Strategic Gain |
|---|---|---|---|
| Typical Minimum Order Scale | 1 kg – 250 kg (Specialized Custom Batches) | 5,000 kg – 20,000 kg (Rigid Standard Tooling) | Preserves capital; minimizes raw active scrap |
| Extraction Parameter Flexibility | Real-time adjustment of temperature, pressure, & solvents | Hardwired thermal cycles; fixed solvent configurations | Isolates volatile compounds without degradation |
| Analytical Tracking (HPLC/HPTLC) | Continuous in-line sampling; full chromatogram capture | End-point composite sampling only | Pinpoints degradation mechanisms instantly |
| Preclinical Regulatory Suitability | Directly aligned with GLP/GCP dosage protocols | Excessive quantity; uncalibrated for animal/cell assay | Ready for instant IND/NDA dossier integration |
| Cycle Turnaround Window | 2 to 4 Weeks from Herb Ingestion to Certificate of Analysis | 3 to 6 Months queue time and setup overhead | Drastically accelerates market launch readiness |
From raw-material screening in provincial cultivation centers to finished multi-dose formulation packaging.
Screening harvest seasons, geographical microclimates, and soil profiles. We quantify variance across nearly 400 single-herb species to secure stable phytochemical concentration benchmarks.
Evaluating dynamic countercurrent extraction, supercritical fluid extraction, membrane concentration, and spray-drying matrices to maximize active bioavailability and reduce manufacturing footprints.
In vitro assays, acute/chronic toxicological screening (LD50), animal pharmacokinetic modeling, and validated analytical fingerprint generation satisfying FDA, EMA, and NMPA standards.
Bridging traditional botanical pharmacology with consumer-ready dosage units across healthcare, functional food, and cosmetic verticals.
Development of stable softgels, two-piece hard capsules, functional effervescent tablets, and direct-dissolve instant herbal sachets supported by verified active marker compounds.
56 certified hospital preparation registrations built on clinical validation of 83 classic Traditional Chinese Medicine (TCM) compounds converted into modern, clean-label oral liquids and concentrated extracts.
Solvent-free essential oils, anti-inflammatory polysaccharide fractions, and skin-penetrating plant bio-actives rigorously tested for dermal irritation, mutagenicity, and stability.
Transparent insights into operational capabilities, quality control mechanisms, and intellectual property containment.
Select your target operational module to engage MedGence scientists for immediate protocol design and batch estimation.
Biomolecular screening, cell viability testing, and receptor binding assays for early-stage actives.
Explore Service
Multi-regional botanical sample comparative analyses to pinpoint superior feedstock quality.
Explore Service
Targeted molecular identification using LC-MS/MS and high-resolution chemical libraries.
Explore Service
Preclinical toxicology and pharmacokinetic validations conducted in accredited testing facilities.
Explore Service
Full chromatographic protocol development, standard reference validation, and ICH documentation.
Explore Service
Rigorous human clinical trials verifying formulation safety, bioavailability, and targeted efficacy.
Explore Service
Custom low-volume manufacturing setups testing separation, distillation, and crystallization.
Explore Service
Trial batch compounding of capsules, tablets, softgels, and oral concentrates under strict controls.
Explore Service